1985 Ford Mustang Gt T Top on 2040-cars

Auto blog

10 automakers shack up in Detroit hotel to talk Takata airbags

Since Takata has decided not to take the lead concerning potential issues with its airbag inflators, the automakers have. Perhaps that's unsurprising, since it's the automakers, not Takata, that will take a beating on the dealership floor if consumers decide its models are a health hazards. The Detroit News reports that Toyota, Honda, General Motors, Ford, Chrysler, Mazda, BMW, Nissan, Mitsubishi and Subaru met in a hotel conference room near the Detroit Metropolitan Airport last week to sort out a way to understand the technical issues involved. So far, faulty airbag inflators have been ruled the cause of five deaths and 50 injuries around the world, but neither Takata nor investigators understands exactly why the inflators are malfunctioning. The National Highway Traffic Safety Administration recently asked Takata to issue a national recall, Takata declined, citing a minuscule failure rate and the fact that it's still investigating the issue. Toyota and Honda then made an industry-wide appeal for "a coordinated, comprehensive testing program" that would pinpoint the problem inflators and get them replaced, and that's what the Detroit meeting was about. Numerous issues, however, will make this a long row to hoe: simply getting the parts to replace the nearly 20 million inflators in cars recalled around the world so far - even working with other suppliers - will take a years, but more importantly, no one knows if the replacement inflators currently being installed will suffer the same issue. Answers will hopefully come quickly with Takata, the ten automakers and NHTSA all independently investigating the problem.

Ford says utility vehicles are key to global growth

While most of us believe that small, fuel efficient cars are the key to global expansion for US automakers, Jim Farley, Ford's vice president of Global Marketing, thinks otherwise. Last week, we attended an exclusive sneak preview of the Ford Edge Concept in advance of the Los Angeles Auto Show, and Farley told us that it's actually utility vehicles that will help the Blue Oval gain market share overseas. "There is no other segment in our industry that is growing like utilities," he said. "We expect over the next five years this full family of [utility] vehicles to really drive our growth as a company."
And Farley has the numbers to back it up, too. Ford projects overall automotive sales to grow 23 percent from 2012 to 2017, but the company's utility vehicles are expected to boom by an impressive 41 percent during that same period. Much of that growth will be in China, where Ford estimates its utility sales will explode. "The biggest opportunity for us globally for utilities is in China," Farley said. "China utility growth is expected to more than double from where it is today to 2017, which isn't that far away." Most astounding is that Ford projects its own utility sales in China will eventually increase by more than 2,000 percent when smaller crossovers, such as the EcoSport and Kuga (sold as the Escape in North America), and the Edge and Explorer, are factored in.
Ford's VP also expects utilities to lead the way in the struggling European market. "With all the difficulties of the European market, there is one segment that has actually expanded in volume over the last several years even though the market is way down, and that's utilities," Farley told us. Ford estimates that their utility sales will grow 65 percent in Europe from 2012-2017. "The utility segment is projected to grow we think about thirty percent between now and 2017 in Europe, and we think we are going to grow twice that rate as a brand," Farley continued.

Britain orders 10,000 ventilators from F1/McLaren/Mercedes/Ford/Rolls-Royce/Airbus

Paramedics and ambulance personnel get instructions from a command unit outside London's ExCel Centre arena, which is being turned into a 4,000 bed temporary hospital called NHS Nightingale to deal with coronavirus patients. The hospital is due to open Monday, March 30. / AP     LONDON — Britain has ordered 10,000 ventilators from a consortium of leading aerospace, engineering and Formula One racing companies which will start production this week in response to an urgent government call for industry to help save lives. The 27-strong team, including Airbus, BAE Systems, Ford and Rolls-Royce, have joined forces to ramp up production of a ventilator made by Smiths Group, which supports those with complications from COVID-19. The consortium, which also includes seven Formula One teams including McLaren and Mercedes, home to World Champion Lewis Hamilton, said they had pulled staff off existing projects to meet the national need. Some 1,228 people have died from coronavirus in the United Kingdom and a senior health official said on Saturday the country would be doing well if it manages to keep the death toll below 20,000. "This consortium brings together some of the most innovative companies in the world," Dick Elsy, the head of the consortium, said in a statement. "I am confident this consortium has the skills and tools to make a difference and save lives." The United Kingdom, which initially only had 5,000 ventilators available in its National Health Service, has been trying to secure additional supplies after realising it needed 30,000 to cope with the peak of the outbreak. Prime Minister Boris Johnson, who is now in isolation in Downing Street after testing positive for coronavirus, made an emergency appeal earlier this month for manufacturers to retool their production lines and start making specialist health equipment including ventilators. Britain now has about 8,000 ventilators, with another 8,000 on order from international manufacturers that are due in coming weeks. Last week it placed an order for a newly-designed model from the vacuum cleaner company Dyson that will need to be approved by the health regulator. Mercedes part of a separate effort, too Separately on Monday a second consortium including Mercedes Formula One and other F1 teams said it had developed in less than a week a new version of a breathing aid that can help coronavirus patients.